SKOPJE (North Macedonia), March 5 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its consolidated net profit grew by an annual 34% to 133.9 million denars ($2.4 million/2.2 million euro) in 2019, backed by higher revenue.